PRFX NASDAQ
PRF Technologies Ltd.
1W: -12.6%
1M: -44.7%
3M: -54.4%
YTD: -58.2%
1Y: -23.6%
3Y: -99.0%
5Y: -99.7%
$1.51
-0.02 (-1.31%)
Pre-Market: $1.48 (-0.03, -1.99%)
Weekly Expected Move ±8.3%
$1
$1
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$0.1M
52W Range1.41-17.95
Volume15,422
Avg Volume519,444
Beta0.77
Dividend—
Analyst Ratings
Company Info
CEOEfraim Cohen-Arazi
Employees2
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2020-09-01
Websiteprf-tech.com
65 Yigal Alon Street
Tel Aviv 6745442
IL
Tel Aviv 6745442
IL
972 3 717 7050
About PRF Technologies Ltd.
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
Latest News
PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial
EXCLUSIVE: PRF Technologies Advances Drop-Less Drug For Cataract Surgery Pain
What's Going On With Pharma Company PRF Technologies On Tuesday?
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's Intraday Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Aviel Sigal | 3,000 | $15.75 | 2026-03-18 | |
| Cohen-Arazi Efraim | 3,000 | $15.75 | 2026-03-18 | |
| Broder Eyal | 2,000 | $15.75 | 2026-03-18 | |
| Shavit Asaf | 3,000 | $5.55 | 2026-03-18 | |
| Aviel Sigal | 612 | $30.00 | 2026-03-18 |